Heron Therapeutics, Inc. (HRTX) Ownership

$1.32

north_east
$0.02 (1.54%)
Day's range
$1.29
Day's range
$1.37

Heron Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RUBRIC CAPITAL MANAGEMENT LP 11/14/2025 29.10 M $36.67 M   8.94% 18.89%
ADAGE CAPITAL PARTNERS GP, L.L.C. 11/14/2025 10.24 M $12.90 M   30.40% 6.65%
BLACKROCK, INC. 11/12/2025 9.99 M $12.58 M   -1.13% 6.48%
CLEARLINE CAPITAL LP 11/14/2025 9.71 M $12.24 M   1,033.10% 6.31%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 11/14/2025 8.75 M $11.03 M   25.28% 5.68%
VANGUARD GROUP INC 11/07/2025 8.46 M $10.66 M   -0.14% 5.49%
PALISADE CAPITAL MANAGEMENT, LP 11/14/2025 7.33 M $9.23 M   44.05% 4.76%
TEJARA CAPITAL LTD 11/04/2025 4.59 M $5.78 M   1.60% 2.98%
BAKER BROS. ADVISORS LP 11/14/2025 4.25 M $5.36 M   100.00% 2.76%
STATE STREET CORP 11/14/2025 3.65 M $4.60 M   5.47% 2.37%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 3.64 M $4.59 M   2.14% 2.37%
TANG CAPITAL MANAGEMENT LLC 11/14/2025 3.45 M $4.35 M   61.56% 2.24%
JW ASSET MANAGEMENT, LLC 11/07/2025 3.29 M $4.15 M   40.85% 2.14%
D. E. SHAW & CO., INC. 11/14/2025 3.09 M $3.89 M   -3.49% 2.01%
UBS GROUP AG 11/13/2025 2.93 M $3.70 M   -7.88% 1.91%
CONGRESS PARK CAPITAL LLC 10/08/2025 2.89 M $3.64 M   27.42% 1.88%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 2.85 M $3.60 M   6.16% 1.85%
CITADEL ADVISORS LLC 11/14/2025 2.71 M $3.41 M   21.90% 1.76%
NEW YORK STATE COMMON RETIREMENT FUND 11/03/2025 2.58 M $3.25 M   46.40% 1.67%
CITIGROUP INC 11/10/2025 2.48 M $3.12 M   4,666.86% 1.61%
MORGAN STANLEY 11/14/2025 2.47 M $3.11 M   -10.63% 1.60%
CAPTION MANAGEMENT, LLC 11/14/2025 2.00 M $2.52 M   100.00% 1.30%
AQR CAPITAL MANAGEMENT LLC 11/14/2025 1.94 M $2.44 M   3,036.39% 1.26%
GOLDMAN SACHS GROUP INC 11/14/2025 1.32 M $1.67 M   26.98% 0.86%
MARSHALL WACE, LLP 11/13/2025 1.31 M $1.65 M   -54.77% 0.85%
JPMORGAN CHASE & CO 11/26/2025 1.29 M $1.63 M   35.61% 0.84%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 1.28 M $1.61 M   7.67% 0.83%
NORTHERN TRUST CORP 11/14/2025 1.16 M $1.46 M   0.43% 0.75%
MONACO ASSET MANAGEMENT SAM 11/10/2025 1.00 M $1.26 M   -7.18% 0.65%
STONEPINE CAPITAL MANAGEMENT, LLC 11/13/2025 850.10 K $1.07 M   29.32% 0.55%
CM MANAGEMENT, LLC 11/13/2025 750.00 K $945.00 K   25.00% 0.49%
CAPTION MANAGEMENT, LLC 11/14/2025 734.30 K $925.21 K   100.00% 0.48%
BANK OF AMERICA CORP /DE/ 11/14/2025 732.07 K $922.41 K   -31.92% 0.48%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2025 700.00 K $882.00 K   0.00% 0.45%
TWO SIGMA INVESTMENTS, LP 11/14/2025 692.28 K $872.27 K   -26.40% 0.45%
ORCHARD CAPITAL MANAGEMENT, LLC 11/12/2025 677.29 K $853.39 K   2.63% 0.44%
RICHMOND BROTHERS, INC. 11/10/2025 572.12 K $720.87 K   3.18% 0.37%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 525.77 K $662.48 K   6.63% 0.34%
NEXPOINT ASSET MANAGEMENT, L.P. 11/14/2025 475.75 K $599.45 K   0.00% 0.31%
PALE FIRE CAPITAL SE 11/13/2025 471.19 K $593.70 K   100.00% 0.31%
BANK OF NEW YORK MELLON CORP 11/03/2025 412.47 K $519.72 K   2.58% 0.27%
BNP PARIBAS ARBITRAGE, SNC 11/13/2025 378.59 K $477.02 K   23.79% 0.25%
NUVEEN, LLC 11/12/2025 347.07 K $437.30 K   0.00% 0.23%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 328.97 K $414.50 K   -23.86% 0.21%
BARCLAYS PLC 11/12/2025 279.36 K $351.99 K   -13.09% 0.18%
MILLENNIUM MANAGEMENT LLC 11/14/2025 248.50 K $313.11 K   -49.53% 0.16%
CYNDEO WEALTH PARTNERS, LLC 10/10/2025 248.09 K $312.59 K   0.00% 0.16%
LOS ANGELES CAPITAL MANAGEMENT LLC 10/20/2025 246.41 K $310.48 K   -7.41% 0.16%
INVESCO LTD. 11/13/2025 231.40 K $291.56 K   33.69% 0.15%
RHUMBLINE ADVISERS 11/06/2025 224.65 K $283.05 K   1.00% 0.15%

Heron Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 259 institutional investors and hedge funds held shares of Heron Therapeutics, Inc.. The most heavily invested institutionals were:

Rubric Capital Management LP: 29.1 M

ADAGE CAPITAL PARTNERS GP, L.L.C.: 10.24 M

BlackRock, Inc.: 9.99 M

Clearline Capital LP: 9.71 M

Velan Capital Investment Management LP: 8.75 M

VANGUARD GROUP INC: 8.46 M

99.12% of Heron Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 174.61 M shares in the last 24 months. This purchase volume represents approximately $230.48 M in transactions.